MP:0000189 | hypoglycemia | "low levels of plasma glucose in the circulating blood; this generally refers to a pathological state" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8] |
Show
Allelic Composition: Pkd1tm1Jzh/Pkd1tm1Jzh Genetic Background: either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c)
|
MP:0001177 | atelectasis | "collapse of the lung or any portion of the lung, or decreased or absent air in the lung, resulting in loss of lung volume " [Stedman s Medical Dictionary:ISBN 0-683-40008-8, J:54931, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Pkd1tm1Jzh/Pkd1tm1Jzh Genetic Background: either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c)
|
MP:0001302 | eyelids open at birth | "widely open eyes instead of closed at perinatal stage" [J:51966] |
Show
Allelic Composition: Pkd1tm1Jzh/Pkd1tm1Jzh Genetic Background: either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c)
|
MP:0001732 | postnatal growth retardation | "slow or limited development after birth " [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Pkd1tm1Jzh/Pkd1tm1Jzh Genetic Background: either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c)
|
MP:0001798 | impaired macrophage phagocytosis | "reduced ability of these phagocytic cells to internalize particulate matter" [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg,Lyz2tm1(cre)Ifo/Lyz2+ Genetic Background: involves: 129P2/OlaHsd
|
MP:0002083 | premature death | "death after 3 weeks of age, but before normal life span" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Pkd1tm1Jzh/Pkd1tm1Jzh Genetic Background: either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c)
|
MP:0002412 | increased susceptibility to bacterial infection | "greater likelihood that an organism will develop ill effects from a bacterial infection or from components of or toxins produced by bacteria" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg,Lyz2tm1(cre)Ifo/Lyz2+ Genetic Background: involves: 129P2/OlaHsd
|
MP:0002451 | abnormal macrophage physiology | "abnormal function or response of the phagocytic leukocytes involved in innate immunity, early non-adaptive phases of host-defense, antigen presentation, and which act as effector cells in humoral and cell-mediated immunity" [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg,Lyz2tm1(cre)Ifo/Lyz2+ Genetic Background: involves: 129P2/OlaHsd
|
MP:0002715 | reduced glycogen catabolism rate | "decreased breakdown of this highly branched polysaccharide composed of glucose subunits; glycogen is the major carbohydrate storage form in the body " [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Pkd1tm1Jzh/Pkd1tm1Jzh Genetic Background: either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c)
|
MP:0003884 | decreased macrophage count | "fewer than the normal numbers of macrophages" [acv:Alicia Valenzuela, Genetic Resources Curator] |
Show
Allelic Composition: Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg,Lyz2tm1(cre)Ifo/Lyz2+ Genetic Background: involves: 129P2/OlaHsd
|
MP:0004028 | chromosome breakage | "chromosome instability in the from of increased frequency of spontaneous breakage with or without rearrangements" [llw2:Linda Washburn , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Hmgb1tm1Meb/Hmgb1tm1Meb Genetic Background: involves: 129P2/OlaHsd * CD-1
|
MP:0004761 | susceptibility to induced pancreatitis | "more likely than normal to develop an inflammatory response, or an increased inflammatory response in the pancreatic tissue after experimental manipulation" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator", MGI:hdene "Howard Dene, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Ptentm1Hwu/Ptentm1Hwu,Trp53tm2Tyj/Trp53+,Amhr2tm3(cre)Bhr/Amhr2+ Genetic Background: involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd
|
MP:0005150 | cachexia | "general weight loss and wasting occurring in the course of chronic disease" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Pkd1tm1Jzh/Pkd1tm1Jzh Genetic Background: either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c)
|
MP:0005202 | lethargy | "mild impairment of consciousness resulting in reduced alertness and awareness; ultimately due to generalized brain dysfunction" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Pkd1tm1Jzh/Pkd1tm1Jzh Genetic Background: either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c)
|
MP:0008553 | increased circulating tumor necrosis factor level | "greater amount in the blood of a serum glycoprotein produced by activated macrophages and NK cells and involved in initiating local inflammatory responses, particularly by its action on the endothelium of local blood vessels; its actions result in increased vascular permeability and induction of expression of adhesion molecules on the endothelium" [ISBN:0-8153-1691-7 "Immunobiology, The Immune System in Health and Disease", MESH:D12.644.276.374.500.800] |
Show
Allelic Composition: Ptentm1Hwu/Ptentm1Hwu,Trp53tm2Tyj/Trp53+,Amhr2tm3(cre)Bhr/Amhr2+ Genetic Background: involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd
|
MP:0008596 | increased circulating interleukin-6 level | "increase in the amount in the blood of a cytokine that stimulates the growth and differentiation of B-cells and is also a growth factor for hybridomas and plasmacytomas, and is produced by many different cells including T-cells, monocytes and fibroblasts" [MESH:D12.644.276.374.465.506] |
Show
Allelic Composition: Ptentm1Hwu/Ptentm1Hwu,Trp53tm2Tyj/Trp53+,Amhr2tm3(cre)Bhr/Amhr2+ Genetic Background: involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd
|
MP:0008635 | increased circulating interleukin-18 level | "increase in the amount in the blood of a cytokine which enhances the cytotoxic activity of NK cells and cytotoxic T-cells and appears to play a role both as neuroimmunomodulator and in the induction of mucosal immunity" [MESH:D12.644.276.374.465.518] |
Show
Allelic Composition: Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg,Lyz2tm1(cre)Ifo/Lyz2+ Genetic Background: involves: 129P2/OlaHsd
Allelic Composition: Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: involves: 129P2/OlaHsd * C57BL/6 * DBA
Allelic Composition: Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg,Tg(Itgax-cre)1-1Reiz/0 Genetic Background: involves: 129P2/OlaHsd * C57BL/6 * CBA
|
MP:0008641 | increased circulating interleukin-1 beta level | "increased in the amount in the blood of an interleukin-1 subtype that is synthesized as an inactive membrane-bound pro-protein on monocytes, macrophages and other cells; proteolytic processing of the precursor form by caspase 1 results in release of the active form of interleukin-1beta from the membrane" [MESH:D12.644.276.374.465.501.600] |
Show
Allelic Composition: Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg,Lyz2tm1(cre)Ifo/Lyz2+ Genetic Background: involves: 129P2/OlaHsd
Allelic Composition: Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: involves: 129P2/OlaHsd * C57BL/6 * DBA
Allelic Composition: Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg,Tg(Itgax-cre)1-1Reiz/0 Genetic Background: involves: 129P2/OlaHsd * C57BL/6 * CBA
|
MP:0008657 | increased interleukin-1 beta secretion | "increase in the production or release of an interleukin-1 subtype that is synthesized as an inactive membrane-bound pro-protein on monocytes, macrophages and other cells; proteolytic processing of the precursor form by caspase 1 results in release of the active form of interleukin-1beta from the membrane" [MESH:D12.644.276.374.465.501.600] |
Show
Allelic Composition: Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg,Lyz2tm1(cre)Ifo/Lyz2+ Genetic Background: involves: 129P2/OlaHsd
|
MP:0008684 | increased interleukin-18 secretion | "increase in the production or release of a cytokine which enhances the cytotoxic activity of NK cells and cytotoxic T-cells and appears to play a role both as neuroimmunomodulator and in the induction of mucosal immunity" [MESH:D12.644.276.374.465.518] |
Show
Allelic Composition: Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg,Lyz2tm1(cre)Ifo/Lyz2+ Genetic Background: involves: 129P2/OlaHsd
|
MP:0008735 | increased susceptibility to endotoxin shock | "more than the expected early reaction of the microcirculation to endotoxins such as LPS, characterized by movement of fluid and leukocytes from the blood into extravascular tissues and often resulting in death" [MGI:tmeehan "Terry Meehan, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg,Lyz2tm1(cre)Ifo/Lyz2+ Genetic Background: involves: 129P2/OlaHsd
|
MP:0008806 | increased circulating amylase level | "greater concentration of a group of amylolytic enzymes that cleave starch, glycogen, and related alpha-1,4-glucans in the blood" [ISBN:0-683-40008-8 "Stedman s Medical Dictionary, 27th edition", MESH:D08.811.277.450.066] |
Show
Allelic Composition: Ptentm1Hwu/Ptentm1Hwu,Trp53tm2Tyj/Trp53+,Amhr2tm3(cre)Bhr/Amhr2+ Genetic Background: involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd
|
MP:0008943 | increased sensitivity to induced cell death | "decrease in the exposure level to an agent that is required to induce cessation of function at the cellular level" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg,Lyz2tm1(cre)Ifo/Lyz2+ Genetic Background: involves: 129P2/OlaHsd
|
MP:0009148 | pancreas necrosis | "pathological cell death in the pancreas, usually due to irreversible damage" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Ptentm1Hwu/Ptentm1Hwu,Trp53tm2Tyj/Trp53+,Amhr2tm3(cre)Bhr/Amhr2+ Genetic Background: involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd
|
MP:0011080 | increased macrophage apoptosis | "greater incidence of cell death in macrophages" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg,Lyz2tm1(cre)Ifo/Lyz2+ Genetic Background: involves: 129P2/OlaHsd
|
MP:0011087 | complete neonatal lethality | "death of all organisms of a given genotype in a population within the neonatal period after birth (Mus: P0)" [MGI:csmith] |
Show
Allelic Composition: Pkd1tm1Jzh/Pkd1tm1Jzh Genetic Background: either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c)
Allelic Composition: Hmgb1tm1Meb/Hmgb1tm1Meb Genetic Background: involves: 129P2/OlaHsd * CD-1
Allelic Composition: Hmgb1tm1.1Ttg/Hmgb1tm1.2Ttg,Tg(CAG-cre)13Miya/0 Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0011971 | increased circulating lactate dehydrogenase level | "elevated blood level of the tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of lactate and pyruvate; measurements of circulating levels are used clinically as a diagnostic indicator of tissue breakdown, some forms of cancer or particular infection types" [MeSH:D08.811.682.047.551.400, MGI:csmith] |
Show
Allelic Composition: Ptentm1Hwu/Ptentm1Hwu,Trp53tm2Tyj/Trp53+,Amhr2tm3(cre)Bhr/Amhr2+ Genetic Background: involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd
|